Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
33.29
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Genus Market Cap
Genus has a market cap or net worth of $2.39 billion as of August 22, 2025. Its market cap has increased by 62.81% in one year.
Market Cap
2.39B
Enterprise Value
2.73B
Revenue
840.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
$33.29
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 50.66M to 2.39B, an increase of 4,614.00%. That is a compound annual growth rate of 14.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 2.39B | 87.33% |
| Dec 31, 2024 | 1.27B | -29.66% |
| Dec 29, 2023 | 1.81B | -22.93% |
| Dec 30, 2022 | 2.35B | -46.03% |
| Dec 31, 2021 | 4.36B | 17.14% |
| Dec 31, 2020 | 3.72B | 36.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |